Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors

Previous reports have indicated that in vitro biliary clearance (Clbiliary) determined in sandwich-cultured hepatocytes correlates well with in vivo Clbiliary for limited sets of compounds. The purpose of this study was 1) to determine the in vitro Clbiliary in sandwich-cultured human hepatocytes of...

Full description

Saved in:
Bibliographic Details
Published inDrug metabolism and disposition Vol. 37; no. 3; pp. 447 - 452
Main Authors Abe, Koji, Bridges, Arlene S., Brouwer, Kim L.R.
Format Journal Article
LanguageEnglish
Published Bethesda, MD Elsevier Inc 01.03.2009
American Society for Pharmacology and Experimental Therapeutics
Subjects
Online AccessGet full text
ISSN0090-9556
1521-009X
1521-009X
DOI10.1124/dmd.108.023465

Cover

More Information
Summary:Previous reports have indicated that in vitro biliary clearance (Clbiliary) determined in sandwich-cultured hepatocytes correlates well with in vivo Clbiliary for limited sets of compounds. The purpose of this study was 1) to determine the in vitro Clbiliary in sandwich-cultured human hepatocytes of angiotensin II receptor blockers and HMG-CoA reductase inhibitors that undergo limited metabolism and 2) to compare the predicted Clbiliary values with estimated in vivo hepatic clearance data in humans. The average biliary excretion index and in vitro intrinsic Clbiliary values of olmesartan, valsartan, pravastatin, rosuvastatin, and pitavastatin in sandwich-cultured human hepatocytes were 35, 23, 31, 25, and 16%, respectively, and 0.943, 1.20, 0.484, 3.39, and 5.48 ml/min/kg, respectively. Clbiliary values predicted from sandwich-cultured human hepatocytes correlated with estimated in vivo hepatic clearance values based on published data (no in vivo data in humans was available for pitavastatin), and the rank order was also consistent. In conclusion, in vitro Clbiliary determined in sandwich-cultured human hepatocytes can be used to predict in vivo Clbiliary of compounds in humans.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
ABBREVIATIONS: Clbiliary, biliary clearance; ARB, angiotensin II receptor blocker; CDFDA, 5 (and 6)-carboxy-2′,7′-dichlorofluorescein diacetate; CDF, 5 (and 6)-carboxy-2′,7′-dichlorofluorescein; HBSS, Hank's balanced salt solution; BEI, biliary excretion index; AUC, area under the medium concentration-time curve; MRP, multidrug resistance-associated protein; OATP, organic anion-transporting polypeptide.
This work was supported by the National Institutes of Health National Institute of General Medical Sciences [Grant GM 41935].
doi:10.1124/dmd.108.023465.
Address correspondence to: Dr. Kim L. R. Brouwer, University of North Carolina School of Pharmacy, Kerr Hall, CB#7360, Chapel Hill, NC 27599-7360. E-mail: kbrouwer@unc.edu
ISSN:0090-9556
1521-009X
1521-009X
DOI:10.1124/dmd.108.023465